Latest Insider Transactions at Beam Therapeutics Inc. (BEAM)
This section provides a real-time view of insider transactions for Beam Therapeutics Inc. (BEAM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Beam Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Beam Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
53,500
+24.75%
|
$0
$0.67 P/Share
|
|
Nov 06
2024
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
51,110
-31.89%
|
$1,328,860
$26.36 P/Share
|
|
Oct 14
2024
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
51,110
-24.18%
|
$1,328,860
$26.27 P/Share
|
|
Oct 14
2024
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
41,754
+6.23%
|
$167,016
$4.04 P/Share
|
|
Oct 01
2024
|
Bethany J Cavanagh SVP, Finance and Treasurer |
SELL
Open market or private sale
|
Direct |
289
-0.64%
|
$6,647
$23.48 P/Share
|
|
Oct 01
2024
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
385
-0.37%
|
$8,855
$23.48 P/Share
|
|
Sep 30
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-6.01%
|
$1,440,000
$24.6 P/Share
|
|
Sep 30
2024
|
Bethany J Cavanagh SVP, Finance and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.24%
|
-
|
|
Jul 02
2024
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
748
-1.08%
|
$16,456
$22.95 P/Share
|
|
Jul 01
2024
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
502
-0.72%
|
$11,546
$23.76 P/Share
|
|
Jun 27
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-5.67%
|
$1,440,000
$24.5 P/Share
|
|
Apr 26
2024
|
Terry Ann Burrell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+13.14%
|
-
|
|
Apr 02
2024
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,530
-19.09%
|
$495,900
$30.54 P/Share
|
|
Apr 01
2024
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,401
-3.15%
|
$108,832
$32.12 P/Share
|
|
Apr 01
2024
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,157
-7.63%
|
$229,024
$32.13 P/Share
|
|
Apr 01
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
18,102
-1.68%
|
$579,264
$32.13 P/Share
|
|
Apr 01
2024
|
Terry Ann Burrell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,446
-7.21%
|
$174,272
$32.12 P/Share
|
|
Apr 01
2024
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
4,534
-2.6%
|
$145,088
$32.12 P/Share
|
|
Mar 31
2024
|
Christine Bellon Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+20.3%
|
-
|
|
Mar 31
2024
|
Giuseppe Ciaramella President |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+16.73%
|
-
|
|
Mar 31
2024
|
Amy Simon Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+22.68%
|
-
|
|
Mar 31
2024
|
Terry Ann Burrell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+26.68%
|
-
|
|
Mar 31
2024
|
John M. Evans CEO |
BUY
Grant, award, or other acquisition
|
Direct |
77,500
+6.72%
|
-
|
|
Mar 28
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-5.67%
|
$1,980,000
$33.86 P/Share
|
|
Feb 14
2024
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
900,000
-21.79%
|
$27,000,000
$30.93 P/Share
|
|
Feb 13
2024
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
1,565
-0.03%
|
$46,950
$30.61 P/Share
|
|
Jan 31
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-5.37%
|
$1,500,000
$25.33 P/Share
|
|
Jan 03
2024
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,907
-2.31%
|
$49,582
$26.42 P/Share
|
|
Dec 22
2023
|
Fmr LLC |
SELL
Other acquisition or disposition
|
Indirect |
29,549
-1.05%
|
-
|
|
Nov 20
2023
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.57%
|
$300,000
$30.5 P/Share
|
|
Nov 20
2023
|
Christine Bellon Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.27%
|
$70,000
$7.22 P/Share
|
|
Oct 30
2023
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,448
-5.0%
|
$62,064
$18.7 P/Share
|
|
Oct 20
2023
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
90,900
+39.51%
|
$0
$0.67 P/Share
|
|
Oct 02
2023
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
388
-0.47%
|
$8,536
$22.85 P/Share
|
|
Jul 24
2023
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
1,206
-2.44%
|
$38,592
$32.01 P/Share
|
|
Jul 24
2023
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,206
+2.38%
|
$8,442
$7.22 P/Share
|
|
Jul 21
2023
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
155,324
-76.3%
|
$4,970,368
$32.06 P/Share
|
|
Jul 21
2023
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
91,284
+18.67%
|
$638,988
$7.22 P/Share
|
|
Jul 10
2023
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
391
-0.56%
|
$11,730
$30.48 P/Share
|
|
Apr 04
2023
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,654
-7.3%
|
$337,966
$29.43 P/Share
|
|
Apr 04
2023
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,161
-1.38%
|
$33,669
$29.09 P/Share
|
|
Apr 04
2023
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
1,754
-1.54%
|
$50,866
$29.09 P/Share
|
|
Apr 04
2023
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
6,493
-0.58%
|
$188,297
$29.09 P/Share
|
|
Apr 04
2023
|
Terry Ann Burrell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,186
-4.43%
|
$63,394
$29.09 P/Share
|
|
Apr 03
2023
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,445
-5.2%
|
$133,350
$30.31 P/Share
|
|
Apr 03
2023
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
931
-1.1%
|
$27,930
$30.31 P/Share
|
|
Apr 03
2023
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
1,918
-1.65%
|
$57,540
$30.31 P/Share
|
|
Apr 03
2023
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
5,161
-0.46%
|
$154,830
$30.31 P/Share
|
|
Apr 03
2023
|
Terry Ann Burrell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,454
-4.74%
|
$73,620
$30.31 P/Share
|
|
Mar 31
2023
|
Christine Bellon Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+17.09%
|
-
|